Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Sue Hughes

  • News

    Alien cells may explain COVID-19 brain fog

    February 18, 2021

    Occlusion of a multitude of tiny vessels by megalokaryocytes may explain the cognitive issues seen in some patients with COVID-19 infection.

  • News

    ACEIs, ARBs safe to continue in COVID-19: Trial published

    January 22, 2021

    Recent data suggest that immune dysfunction may contribute to poor outcomes among COVID-19 patients.

  • News

    COVID-19 anticoagulation trials ‘paused’ for futility, safety

    December 22, 2020

    The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.

  • 1
    News

    COVID-19 and risk of clotting: ‘Be proactive about prevention’

    December 8, 2020

    "We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of thromboprophylaxis," authors of a review article say.

  • News

    COVID-19 diagnosed on CTA scan in stroke patients

    October 29, 2020

    “As part of the stroke evaluation workup process, we were able to diagnose COVID-19 at the same time at no extra cost or additional workload.”

  • News

    COVID-19: Thromboembolic events high despite prophylaxis

    October 27, 2020

    “Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”

  • 1
    News

    First randomized trial reassures on ACEIs, ARBs in COVID-19

    September 2, 2020

    The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.

  • News

    Captopril questioned for diabetes patients in COVID-19 setting

    July 2, 2020

    Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers, a new study suggests.

  • News

    CVD risk continues to fall down to systolic BP of 90 mm HG

    June 19, 2020

    “From an individual level we can now say that in healthy individuals, a systolic pressure in the 90s is not too low. It is a positive thing.”

  • News

    COVID-19 neurologic effects: Does the virus directly attack the brain?

    June 5, 2020

    There are neurologic sequelae of COVID-19. “We need to be alert to these, and to try to understand the potential long-term consequences.”

Previous1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences